Clinical Trial

The Relationship Between NLR and PONV and ESPB

Not Yet Recruiting Phase 1

Record status

This record was last updated July 29, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.

Summary

This study aims to investigate whether preoperative NLR (Neutrophil-to-Lymphocyte Ratio) serves as a biomarker for PONV (Postoperative Nausea and Vomiting). It also examines the impact of erector spinae plane block on NLR and PONV. Furthermore, the research explores the effect of erector spinae plane block on postoperative pain relief in spinal surgery and its influence on the usage of opioid medications.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2023-11-09; most recent amendment 2025-07-24.

Trial Details

NCT Number	NCT06127966
Lead Sponsor	Qianfoshan Hospital
Conditions	Erector Spinae Plane Block, Neutrophil to Lymphocyte Ratio
Enrollment	220 participants
Start Date	2025-08-01
Primary Completion	2026-08-01 (estimated)
Study Completion	2026-09-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-29